Type | Public | |
Founded | 2004 | |
HQ | Paris, FR | Map |
Website | sanofi.com | |
Employee Ratings | ||
Overall Culture | A- | More |
EUR | |
---|---|
Revenue (Q1, 2022) | 9.7b |
Gross profit (Q1, 2022) | 7.6b |
Net income (Q1, 2022) | 2.0b |
EBITDA (Q1, 2022) | 2.9b |
EBIT (Q1, 2022) | 2.4b |
Market capitalization (27-May-2022) | 128.5b |
Closing stock price (27-May-2022) | 102.4 |
EV | 128.5b |
EUR | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Revenue | 36.1b | 36.0b | 37.8b |
Cost of goods sold | (10.3b) | (10.5b) | (10.7b) |
Gross profit | 28.7b | 27.5b | 28.9b |
R&D expense | (6.0b) | (5.5b) | (5.7b) |
EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.4b | 8.6b | 9.5b | 9.0b | 8.2b | 9.5b | 8.6b | 8.7b | 10.4b | 9.7b |
Cost of goods sold | (2.6b) | (1.9b) | (3.1b) | (2.9b) | (1.5b) | (3.2b) | (2.7b) | (1.9b) | (3.2b) | (2.9b) |
Gross profit | 6.2b | 7.7b | 7.0b | 6.7b | 14.5b | 7.0b | 6.5b | 7.3b | 7.9b | 7.6b |
R&D expense | (1.4b) | (1.6b) | (1.4b) | (1.3b) | (1.4b) | (1.3b) | (1.3b) | (1.4b) | (1.4b) | (1.5b) |
EUR | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Cash | 9.4b | 13.9b | 10.1b |
Accounts Receivable | 7.9b | 7.5b | 7.6b |
Prepaid Expenses | 1.9b | 2.4b | 2.0b |
Inventories | 8.0b | 8.4b | 8.7b |
EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Cash | 6.7b | 16.0b | 9.7b | |||||||
Accounts Receivable | 7.2b | 7.2b | 6.8b | |||||||
Prepaid Expenses | 623.0m | |||||||||
Inventories | 8.4b | 8.9b | 9.3b |
EUR | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Net Income | 2.6b | 12.0b | 6.2b |
Depreciation and Amortization | 7.5b | ||
Inventories | (547.0m) | (593.0m) | (357.0m) |
Accounts Payable | 169.0m | 86.0m | 451.0m |
EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 968.0m | 968.0m | 9.0b | 9.0b | 2.8b | 2.8b | ||||
Depreciation and Amortization | 3.8b | 3.8b | 2.0b | 2.0b | 1.7b | 1.7b | ||||
Inventories | (934.0m) | (934.0m) | (1.0b) | (1.0b) | (821.0m) | (821.0m) | ||||
Accounts Payable | (49.0m) | (49.0m) | (325.0m) | (325.0m) | (89.0m) | (89.0m) |
Company Name | Date | Deal Size |
---|---|---|
Amunix | December 20, 2021 | $1 b |
Origimm | December 01, 2021 | |
Kadmon | September 08, 2021 | $1.9 b |
Translate Bio | August 03, 2021 | $3.2 b |
Tidal Therapeutics | April 09, 2021 | $160 m |
Kymab | January 11, 2021 | $1.1 b |
Kiadis Pharma | November 02, 2020 | €308 m |
Principia BioPharma | August 17, 2020 | $3.4 b |
Synthorx | December 09, 2019 | $2.5 m |
Ablynx | January 29, 2018 | $4.8 b |
Sanofi revenue breakdown by business segment: 11.8% from HEALTH CARE DIVERSIFIED, 71.4% from PHARMACEUTICALS and 16.7% from VACCINES
A-
75/100
A
77/100
A-
76/100
A-
76/100
When was Sanofi founded?
Sanofi was founded in 2004.
Who are Sanofi key executives?
Sanofi's key executives are Paul Hudson, Serge Weinberg and Olivier Charmeil.
How many employees does Sanofi have?
Sanofi has 95,442 employees.
What is Sanofi revenue?
Latest Sanofi annual revenue is €37.8 b.
What is Sanofi revenue per employee?
Latest Sanofi revenue per employee is €395.6 k.
Who are Sanofi competitors?
Competitors of Sanofi include Viatris, AstraZeneca and Eli Lilly.
Where is Sanofi headquarters?
Sanofi headquarters is located at 54 Rue la Boétie, Paris.
Where are Sanofi offices?
Sanofi has offices in Paris, Ambarès-et-Lagrave, Amilly, Antony and in 109 other locations.
How many offices does Sanofi have?
Sanofi has 119 offices.
Receive alerts for 300+ data fields across thousands of companies